Insider Trading History of Zarrabian Saiid

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Zarrabian Saiid since 2014. This trader's CIK number is 1495521. At the time of last reporting, Zarrabian Saiid was the Head of Strategic Partnerships of Kintara Therapeutics, Inc.. (stock ticker symbol KTRA). Also see all insider trading activities at Kintara Therapeutics, Inc..

Note that in the past Zarrabian Saiid also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at La Jolla Pharmaceutical Co (LJPC) by Zarrabian Saiid

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 LJPC 307 $5,986 0 $0 0 $0
2014 LJPC 381 $3,630 0 $0 0 $0

Yearly summary of insider trading at Kintara Therapeutics, Inc. (KTRA) by Zarrabian Saiid

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 KTRA 50,000 $31,328 0 $0 0 $0
2017 KTRA 60,900 $50,547 0 $0 0 $0


Insider trading activities at 2 companies by Zarrabian Saiid:

1. La Jolla Pharmaceutical Co (LJPC)

2. Kintara Therapeutics, Inc. (KTRA)

Table 1. Insider trading of La Jolla Pharmaceutical Co (LJPC) by Zarrabian Saiid

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-05-14 LJPC Buy 307 19.50 5,986
2014-07-31 LJPC Buy 381 9.53 3,630

Table 2. Insider trading of Kintara Therapeutics, Inc. (KTRA) by Zarrabian Saiid

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-07 KTRA Buy 38,109 .64 24,313
2021-12-06 KTRA Buy 11,891 .59 7,015
2017-11-14 DMPI Buy 60,900 .83 50,547

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zarrabian Saiid (Head of Strategic Partnerships of Kintara Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.